drugset / Trial / NCT05731492
A Study of Macitentan in Children Below 2 Years of Age
NaSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to learn what happens to macitentan and its active metabolite (aprocitentan) in the body of children aged between 1 month and 2 years.
Timeline
- Start
- 2024-03-14
- Primary completion
- 2024-04-01
- Completion
- 2024-04-01
Outcome
Outcome not reported
Stopped (Business): “Sponsor Decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Macitentan | Other / unclassified | — | Oral |